Interleukin-15
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Interleukin-15, covering 2013-11-11 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]